This morning, Citigroup downgraded shares of Juniper Networks (NYSE:JNPR) from buy to hold following weak results earlier in the week. With the downgrade, Citigroup noted that there are questions concerning the company's long term growth prospects and set a $27 price target as a result.
Shares of JNPR were lower again today, falling 2.5% so far.
And Goldman Sachs lowered its price target on shares of Varian Medical (VAR) to $57 as growth could slow at the company. In the report, Goldman reduced its EPS estimates and reiterated its sell rating.
Shares of Varian were lower on Thursday, falling 5.4%.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.